Europe
The keenly awaited ruling should act as a ‘call to arms’ for a much-needed evolution of UK copyright law, says Rebecca Newman at Addleshaw Goddard
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Monika Żuraw, founder of Żuraw & Partners, discusses why IP should be part of the foundation of a business, and taking on projects that others walk away from
Sponsored
Sponsored
-
Sponsored by Gün and PartnersGüldeniz Doğan Alkan and Dilan Sıla Kayalıca of Gün + Partners highlight a Turkish Court of Cassation ruling that shows how a trademark owner’s actions – or inaction – can limit courts’ boundaries in assessing similarity -
Sponsored by Patrinos & KilimirisManolis Metaxakis of Patrinos & Kilimiris Law Offices considers the implications of the EUIPO ruling in favour of the Hellenic Republic concerning the validity of the ‘TurkAegean’ trademark
-
Sponsored by Bird & BirdLiz McAuliffe of Bird & Bird says Intel’s triumph against R2 Semiconductor in the High Court of England and Wales had a limited impact on parallel litigation in other jurisdictions before a high-stakes settlement
-
Sponsored by Maiwald Intellectual PropertyEva Ehlich and Anja Fux of Maiwald discuss a board of appeal decision on G 2/21’s interpretation, including a critical review of the interpretation in T 116/18 while denying a request for further review
-
Sponsored by Gün and PartnersSelin Sinem Erciyas and Zeynep Çağla Üstün explore whether Turkey, as a non-EU state party to the European Patent Convention, might still face the Unified Patent Court’s jurisdiction under EU regulations
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer and Gisela Grabow of Maiwald explore proposed changes to new EU provisions aimed at facilitating faster market entry for generics and biosimilars, so as to allegedly bolster competition and enhance patient access
European Jurisdictions